Adrenaline (Epinephrine) Nebulization Dosing for Children with Croup
For children with croup, the recommended dose of nebulized epinephrine is 0.5 mL/kg of 1:1000 solution (maximum: 5 mL = 5 mg) administered by nebulizer. 1
Dosing Options and Formulations
L-Epinephrine (Standard Epinephrine)
- Dose: 0.5 mL/kg of 1:1000 solution (maximum: 5 mL = 5 mg) 1
- This is the most commonly available form of epinephrine
Racemic Epinephrine
- Dose: 0.05 mL/kg of 2.25% solution (maximum: 0.5 mL) in 2 mL of normal saline 1
- Many institutions use a standard 0.5 mL dose of racemic epinephrine for all patients regardless of weight 1
- If racemic epinephrine is not available, L-epinephrine (1:1000) can be substituted at the dose mentioned above 1
Clinical Considerations
When to Use Nebulized Epinephrine
- Indicated for moderate to severe croup cases 2
- Used to avoid intubation and stabilize children prior to transfer to intensive care 1
- Effective for stridor following intubation 1
Duration of Effect and Monitoring
- Effect is short-lived (1-2 hours) 1, 2
- Patients should be observed for at least 2 hours after administration to monitor for rebound symptoms 2
Important Cautions
- Should not be used in children who are shortly to be discharged or on an outpatient basis 1
- Children requiring two or more epinephrine treatments should be considered for hospitalization 3
Treatment Algorithm
Assess croup severity:
- Mild: Barking cough, no audible stridor at rest, minimal respiratory distress
- Moderate: Barking cough, audible stridor at rest, some respiratory distress
- Severe: Prominent stridor, significant respiratory distress, agitation or lethargy
Treatment based on severity:
Administer nebulized epinephrine:
Monitor response:
Evidence Quality and Considerations
The dosing recommendations are primarily based on guidelines from the American Academy of Pediatrics 1 and British Thoracic Society 1. Evidence suggests no significant difference in efficacy between racemic epinephrine and L-epinephrine 4, so either formulation can be used based on availability.
Research shows that nebulized epinephrine provides clinically significant reduction in croup symptoms at 30 minutes post-treatment 4, making it valuable for acute management, but the short duration of action necessitates close monitoring for symptom recurrence.